Multiple investment and financial firms have recently been engaged in purchasing, selling, and adjusting their holdings of VeriSign, Inc. (NASDAQ:VRSN) stock. This bio-tech company has largely been outperforming market indices like the Nasdaq, Dow, and S&P 500. Some recent shareholders changes include Canoe Financial LP selling 149,100 shares, Alta Capital Management LLC trimming its holdings, and Trust Co. of Oklahoma and Abacus FCF Advisors LLC acquiring new positions. Major sales of shares have also been conducted by various insiders, including CEO D James Bidzos. In the financial performance front, VeriSign's Q1 2025 showed revenues lined up with expectations, and both Q4 2024 and full-year 2024 financial results have been released. Warren Buffet's firm Berkshire Hathaway has expanded its stake in VeriSign, believed to indicate a bullish period ahead. However, VeriSign's status as an attractive investment still provokes a divergent sentiment, as analysts argue if the stock will climb or sink while also noting the stock's substantial growth over the past year.
Verisign VRSN News Analytics from Sun, 24 Nov 2024 08:00:00 GMT to Sat, 21 Jun 2025 13:51:25 GMT -
Rating 6
- Innovation 3
- Information 8
- Rumor -1
